Carestream brings in-vivo multispectral imaging system to market

Carestream Molecular Imaging, a division of Carestream Health, has released a new digital system for fluorescent multispectral optical molecular imaging.

Carestream said its Kodak In-Vivo Multispectral Imaging System FX, which is now available worldwide, is designed to locate and monitor changes in molecular activity of specific cells or organs long before morphological changes can be detected.

The FX system has software generates and analyzes a series of images taken at different wavelengths with spatially co-registered x-ray and white light images for improved localization of biomarkers in vivo. Further, the system’s multimodal capabilities include bioluminescence and radioisotopic signal detection, said Carestream.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.